(S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of KCNK1 mRNA CTD PMID:11478936 1,1-dichloroethene decreases expression ISO Kcnk1 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of KCNK1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Kcnk1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of KCNK1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of KCNK1 mRNA CTD PMID:15576828 and PMID:17557909 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO KCNK1 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of KCNK1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO KCNK1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of KCNK1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KCNK1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Kcnk1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of KCNK1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of KCNK1 mRNA CTD PMID:25975270 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 4,4'-sulfonyldiphenol decreases expression ISO KCNK1 (Homo sapiens) 6480464 bisphenol S results in decreased expression of KCNK1 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression ISO Kcnk1 (Mus musculus) 6480464 bisphenol S results in increased expression of KCNK1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [bisphenol S co-treated with Tretinoin] results in decreased expression of KCNK1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO Kcnk1 (Mus musculus) 6480464 Fenretinide results in increased expression of KCNK1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO KCNK1 (Homo sapiens) 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of KCNK1 mRNA] CTD PMID:21095227 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of KCNK1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of KCNK1 mRNA CTD PMID:30047161 aflatoxin B1 increases expression ISO KCNK1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of KCNK1 mRNA CTD PMID:22100608 all-trans-retinoic acid increases expression ISO KCNK1 (Homo sapiens) 6480464 Tretinoin results in increased expression of KCNK1 mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KCNK1 mRNA and [bisphenol S co-treated with Tretinoin] results in decreased expression of KCNK1 mRNA CTD PMID:30951980 all-trans-retinoic acid decreases expression ISO KCNK1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of KCNK1 mRNA CTD PMID:23724009 amiodarone increases expression ISO Kcnk1 (Mus musculus) 6480464 Amiodarone results in increased expression of KCNK1 mRNA CTD PMID:15520326 amitrole increases expression EXP 6480464 Amitrole results in increased expression of KCNK1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KCNK1 mRNA CTD PMID:16483693 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of KCNK1 gene CTD PMID:28931070 and PMID:35440735 barium(0) multiple interactions ISO Kcnk1 (Mus musculus) 6480464 Barium inhibits the reaction [KCNK1 protein results in increased transport of Potassium] and Barium inhibits the reaction [KCNK1 protein results in increased transport of Sodium] CTD PMID:16847696 benzo[a]pyrene decreases expression ISO Kcnk1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of KCNK1 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO KCNK1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of KCNK1 mRNA CTD PMID:32234424 Benzo[k]fluoranthene increases expression ISO Kcnk1 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of KCNK1 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KCNK1 mRNA CTD PMID:20920545 bisphenol A decreases expression ISO KCNK1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of KCNK1 mRNA CTD PMID:25912373 bisphenol F multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KCNK1 mRNA CTD PMID:30951980 bisphenol F increases expression ISO Kcnk1 (Mus musculus) 6480464 bisphenol F results in increased expression of KCNK1 mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of KCNK1 mRNA CTD PMID:32479839 buta-1,3-diene increases expression ISO Kcnk1 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of KCNK1 mRNA CTD PMID:29038090 captan decreases expression ISO Kcnk1 (Mus musculus) 6480464 Captan results in decreased expression of KCNK1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO KCNK1 (Homo sapiens) 6480464 Carbamazepine affects the expression of KCNK1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Kcnk1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene increases expression ISO Kcnk1 (Mus musculus) 6480464 Chloroprene results in increased expression of KCNK1 mRNA CTD PMID:23125180 choline multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KCNK1 mRNA CTD PMID:20938992 cisplatin affects response to substance ISO KCNK1 (Homo sapiens) 6480464 KCNK1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clofibrate decreases expression ISO Kcnk1 (Mus musculus) 6480464 Clofibrate results in decreased expression of KCNK1 mRNA CTD PMID:17585979 clothianidin decreases expression ISO KCNK1 (Homo sapiens) 6480464 clothianidin results in decreased expression of KCNK1 mRNA CTD PMID:31626844 cobalt dichloride increases expression ISO KCNK1 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of KCNK1 mRNA CTD PMID:19376846 cyclosporin A increases expression ISO KCNK1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of KCNK1 mRNA CTD PMID:20106945 and PMID:27989131 decabromodiphenyl ether multiple interactions EXP 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of KCNK1 mRNA CTD PMID:32207525 deguelin decreases expression ISO KCNK1 (Homo sapiens) 6480464 deguelin results in decreased expression of KCNK1 mRNA CTD PMID:33512557 dexamethasone increases expression ISO Kcnk1 (Mus musculus) 6480464 Dexamethasone results in increased expression of KCNK1 mRNA CTD PMID:19344079 diazinon increases methylation ISO KCNK1 (Homo sapiens) 6480464 Diazinon results in increased methylation of KCNK1 gene CTD PMID:22964155 doramapimod decreases expression EXP 6480464 doramapimod results in decreased expression of KCNK1 mRNA CTD PMID:24303162 dorsomorphin multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA CTD PMID:27188386 entinostat increases expression ISO KCNK1 (Homo sapiens) 6480464 entinostat results in increased expression of KCNK1 mRNA CTD PMID:26272509 epoxiconazole increases expression ISO Kcnk1 (Mus musculus) 6480464 epoxiconazole results in increased expression of KCNK1 mRNA CTD PMID:35436446 ethanol affects splicing ISO Kcnk1 (Mus musculus) 6480464 Ethanol affects the splicing of KCNK1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KCNK1 mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of KCNK1 mRNA CTD PMID:27387713 hexane increases methylation EXP 6480464 n-hexane results in increased methylation of KCNK1 promoter CTD PMID:23740543 inulin multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KCNK1 mRNA CTD PMID:36331819 isotretinoin decreases expression ISO KCNK1 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of KCNK1 mRNA CTD PMID:20436886 L-methionine multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KCNK1 mRNA CTD PMID:20938992 lead(0) increases expression ISO KCNK1 (Homo sapiens) 6480464 Lead results in increased expression of KCNK1 mRNA CTD PMID:19921347 mercury dibromide increases expression ISO KCNK1 (Homo sapiens) 6480464 mercuric bromide results in increased expression of KCNK1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA CTD PMID:27188386 methimazole increases expression EXP 6480464 Methimazole results in increased expression of KCNK1 mRNA CTD PMID:30047161 methotrexate affects response to substance ISO KCNK1 (Homo sapiens) 6480464 KCNK1 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylisothiazolinone increases expression ISO KCNK1 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of KCNK1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO KCNK1 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of KCNK1 mRNA CTD PMID:28001369 monosodium L-glutamate multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of KCNK1 mRNA CTD PMID:19001666 monosodium L-glutamate increases expression ISO Kcnk1 (Mus musculus) 6480464 Sodium Glutamate results in increased expression of KCNK1 mRNA CTD PMID:19001666 N-nitrosodiethylamine multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of KCNK1 mRNA CTD PMID:24535843 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of KCNK1 mRNA CTD PMID:11478936 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of KCNK1 mRNA CTD PMID:33484710 ozone increases expression ISO Kcnk1 (Mus musculus) 6480464 Ozone results in increased expression of KCNK1 mRNA CTD PMID:17095637 ozone multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KCNK1 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA CTD PMID:27188386 paracetamol increases expression ISO KCNK1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of KCNK1 mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of KCNK1 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KCNK1 mRNA CTD PMID:36331819 phenobarbital multiple interactions ISO Kcnk1 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of KCNK1 mRNA more ... CTD PMID:19482888 more ... phenobarbital affects expression ISO Kcnk1 (Mus musculus) 6480464 Phenobarbital affects the expression of KCNK1 mRNA CTD PMID:23091169 phenobarbital decreases response to substance ISO Kcnk1 (Mus musculus) 6480464 KCNK1 results in decreased susceptibility to Phenobarbital CTD PMID:23291559 phenobarbital increases expression ISO Kcnk1 (Mus musculus) 6480464 Phenobarbital results in increased expression of KCNK1 mRNA and Phenobarbital results in increased expression of KCNK1 protein CTD PMID:19270015 more ... phenylmercury acetate increases expression ISO KCNK1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of KCNK1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of KCNK1 mRNA CTD PMID:15215175 pirinixic acid decreases expression ISO Kcnk1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of KCNK1 mRNA CTD PMID:17426115 potassium atom multiple interactions ISO Kcnk1 (Mus musculus) 6480464 Barium inhibits the reaction [KCNK1 protein results in increased transport of Potassium] and Quinidine affects the reaction [KCNK1 protein results in increased transport of Potassium] CTD PMID:16847696 potassium atom increases transport ISO Kcnk1 (Mus musculus) 6480464 KCNK1 protein results in increased transport of Potassium CTD PMID:16847696 propiconazole increases expression ISO Kcnk1 (Mus musculus) 6480464 propiconazole results in increased expression of KCNK1 mRNA CTD PMID:21278054 quinidine multiple interactions ISO Kcnk1 (Mus musculus) 6480464 Quinidine affects the reaction [KCNK1 protein results in increased transport of Potassium] and Quinidine inhibits the reaction [KCNK1 protein results in increased transport of Sodium] CTD PMID:16847696 SB 431542 multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide affects expression ISO KCNK1 (Homo sapiens) 6480464 Silicon Dioxide analog affects the expression of KCNK1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO KCNK1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of KCNK1 mRNA CTD PMID:23806026 sodium atom multiple interactions ISO Kcnk1 (Mus musculus) 6480464 Barium inhibits the reaction [KCNK1 protein results in increased transport of Sodium] and Quinidine inhibits the reaction [KCNK1 protein results in increased transport of Sodium] CTD PMID:16847696 sodium atom increases transport ISO Kcnk1 (Mus musculus) 6480464 KCNK1 protein results in increased transport of Sodium CTD PMID:16847696 sodium dichromate decreases expression ISO Kcnk1 (Mus musculus) 6480464 sodium bichromate results in decreased expression of KCNK1 mRNA CTD PMID:31558096 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of KCNK1 mRNA CTD PMID:30047161 temozolomide increases expression ISO KCNK1 (Homo sapiens) 6480464 Temozolomide results in increased expression of KCNK1 mRNA CTD PMID:31758290 testosterone decreases expression ISO Kcnk1 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of KCNK1 mRNA CTD PMID:33848595 thapsigargin decreases expression ISO KCNK1 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of KCNK1 mRNA CTD PMID:22378314 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of KCNK1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO KCNK1 (Homo sapiens) 6480464 trichostatin A results in increased expression of KCNK1 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA CTD PMID:27188386 tunicamycin decreases expression ISO KCNK1 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of KCNK1 mRNA CTD PMID:22378314 tunicamycin increases expression ISO KCNK1 (Homo sapiens) 6480464 Tunicamycin results in increased expression of KCNK1 mRNA CTD PMID:33545341 valproic acid affects expression ISO Kcnk1 (Mus musculus) 6480464 Valproic Acid affects the expression of KCNK1 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO KCNK1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA CTD PMID:27188386 valproic acid increases expression ISO KCNK1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of KCNK1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO KCNK1 (Homo sapiens) 6480464 Valproic Acid affects the expression of KCNK1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO Kcnk1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of KCNK1 mRNA CTD PMID:21427059 vancomycin decreases expression ISO Kcnk1 (Mus musculus) 6480464 Vancomycin results in decreased expression of KCNK1 mRNA CTD PMID:18930951 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of KCNK1 mRNA CTD PMID:25423262
